Recurrent urogenital herpes simplex-successful treatment with imiquimod?

Sexually Transmitted Infections

Volumn 75, Issue 2, 1999, Pages 132-133

  Christensen, B ^a   Hengge, U R ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; IMIQUIMOD;

CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; HERPES SIMPLEX; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LONG TERM CARE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; UROGENITAL SYSTEM;

ADULT; AMINOQUINOLINES; FEMALE; HERPES GENITALIS; HUMANS; INTERFERON INDUCERS; RECURRENCE;

EID: 0032948641     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Goldberg LH, Kaufman R, Kuriz TO, et al. Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group. Arch Dermatol 1993;129:582-7.
2. Mindel A, WelIer IV, Faherty A, et al. Prophylactic oral acyclovir in recurrent genital herpes. Lancet I984;2:57-9.
3. Lassus A, Bergelin I, Paloranta A, et al. Efficacy of interferon and placebo in the treatment of recurrent genital herpes: a double-blind trial Sex Transm Dis 1987;14:I85-90.
4. Ophir J, Brenner S, Bali R, et al. Effect of topical interferon-beta on recurrence rates in genital herpes: a double-blind placebo-controlled randomized study. J Interferon Cytokine Res 1995; 15:625-31.
5. Testerman TL, Gerstner JF, Imbertson LM, et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leucocyte Biol I995;58:365-72.
6. Slade HB, Owens ML, Tomai MA, el al Imiquimod 5 % cream (Aldara™). Exp Ofin Invest Drugs 1998;7:437-50.
7. Bernstein DI, Miller RL, Harrison CJ. Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2-infection in guinea pigs when begun after lesion developement. Anin-iral Res 1993; 20:45-55.